ScreenPoint Medical Reports the Acquisition of Biomediq, Bolstering its Breast Cancer Risk Evaluation Capabilities

Shots: ScreenPoint has acquired Biomediq, enhancing its breast cancer risk evaluation abilities by adding Breast AI platform, Transpara, that uses Mammographic Texture Risk biomarkers to analyze 2D & 3D mammograms & predict short & long-term risk ScreenPoint has launched Transpara 2.1, with advanced features like automated breast density evaluation (BIRADS & volumetric) & temporal…

BySenior EditorJanuary 9, 2025

NEWS

Boston Scientific to Acquire Bolt Medical, Strengthening its Cardiovascular Portfolio

Shots: Boston Scientific has agreed to acquire Bolt Medical, strengthening its cardiovascular portfolio with the addition of Bolt IVL system for coronary & peripheral disease. Deal is expected to close in H1’25 Boston, an investor with a 26% equity stake in Bolt Medical, is acquiring the rest 74% for $443M upfront & up to…

BySenior EditorJanuary 9, 2025

NEWS

Hologic Completes the Acquisition of Gynesonics for ~$350M

Shots: Hologic has completed the acquisition of Gynesonics, focused on developing minimally invasive women’s health solutions, for ~$350M The acquisition has strengthened Hologic's portfolio with the addition of Sonata System, a minimally invasive solution for heavy periods & fibroids The Sonata System is developed to capture intrauterine images for diagnosis and transcervical treatment…

BySenior EditorJanuary 7, 2025

NEWS

Stryker to Acquire Inari Medical for ~$4.9B

Shots: Stryker has signed a definitive agreement to initiate a tender offer for acquiring all the issued & outstanding shares of Inari Medical for $80 per share in cash, making it a total value of ~$4.9B Upon completion, Stryker will acquire remaining shares in a second-step merger at the same price. The deal is…

BySenior EditorJanuary 7, 2025

NEWS

Galera Therapeutics Completes Nova Pharmaceuticals’ Acquisition

Shots: Galera has completed Nova’s acquisition to form Galera Therapeutics, trading on OTC under GRTX ticker. Acquisition was backed by a $3M investment from a group of investors led by Ikarian Capital Galera issued 21.1M common shares, pre-funded warrants for 23M shares & 119,318 Series B convertible preferred shares. At closing, Galera stockholders will…

BySenior EditorJanuary 1, 2025

CXO TALKS

Spotlight Interview: Moreno Perugini in a Candid Conversation with PharmaShots

Following the Reuters Events Pharma USA 2024, PharmaShots brings an engaging conversation with Moreno Perugini, President, of Néstle Health Science. Moreno begins the conversation by highlighting Néstle’s journey to become a full-fledged pharma company through a series of acquisitions and deals. Moreno recalls Néstle’s transitioning into a pharmaceutical company when the company got the rights for Zenpep,…

ByAditya SinghApril 15, 2024

THOUGHTSPOT

Competitive Intelligence: A Substantial Advantage for the Pharmaceutical Sector

“The supreme art of war is to subdue the enemy without fighting” – Sun Zhu, Competitive Intelligence benefits your organization gather and analyzing information related to your competitor’s business models. This deep analysis helps your organization reduce the strategic risks and increase revenue opportunities by attaining deep insights into how the market has changed and…

BySaurabh ChaubeyOctober 11, 2022

ScreenPoint Medical Reports the Acquisition of Biomediq, Bolstering its Breast Cancer Risk Evaluation Capabilities

Boston Scientific to Acquire Bolt Medical, Strengthening its Cardiovascular Portfolio

Hologic Completes the Acquisition of Gynesonics for ~$350M

Stryker to Acquire Inari Medical for ~$4.9B

Galera Therapeutics Completes Nova Pharmaceuticals’ Acquisition

Spotlight Interview: Moreno Perugini in a Candid Conversation with PharmaShots

Competitive Intelligence: A Substantial Advantage for the Pharmaceutical Sector

Contact US

FOLLOW US